Relaxo Footwears (RELAXO) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
5 Jun, 2025Executive summary
Q3 FY25 revenue declined 6.4% year-over-year to ₹666.9 Cr; 9M FY25 revenue down 3.3% to ₹2,094.5 Cr.
Q3 FY25 PAT fell 14.4% year-over-year to ₹33.0 Cr; 9M FY25 PAT down 18% to ₹114.1 Cr.
Board approved unaudited financial results for Q3 and 9M FY25; auditors issued an unmodified limited review report.
Volume growth: Q3 FY25 pairs sold up to 4.7 Cr from 4.0 Cr year-over-year; 9M FY25 at 14.5 Cr vs 13.2 Cr.
Average realization per pair declined to ₹157 in Q3 FY25 from ₹166 year-over-year.
Financial highlights
Q3 FY25 EBIT margin at 8.1% (down 120 bps year-over-year); PAT margin at 4.95% (down 46 bps).
Diluted EPS for Q3 FY25 at ₹1.32 (down 14.3% year-over-year); 9M FY25 at ₹4.58 (down 17.9%).
Gross margin for Q3 FY25 was 65.9%.
Annual FY24 revenue grew to ₹2,914 Cr; PAT at ₹200.5 Cr with a margin of 6.9%.
Net worth as of H1 FY25 at ₹2,011 Cr; net debt at ₹(151) Cr (net cash position).
Outlook and guidance
Management highlights strong industry growth drivers: rising disposable income, premiumization, and shift to branded footwear.
Focus on cost optimization, manufacturing excellence, and expanding distribution network to drive future growth.
ICRA reaffirmed long-term rating at [ICRA] AA (Stable) and short-term at [ICRA] A1+.
Latest events from Relaxo Footwears
- Q3FY26 saw stable revenue but lower profit, while FY25 ended with strong cash and growth outlook.RELAXO
Q3 25/2630 Jan 2026 - Revenue and profit declined, margins stable, CapEx over INR 100 crore, cash flow improved.RELAXO
Q2 24/2515 Jan 2026 - Q1FY25 revenue up 1.3% year-over-year, but net profit declined as margins contracted.RELAXO
Q1 24/2521 Nov 2025 - Margins stable despite lower sales; growth expected as distribution revamp settles.RELAXO
Q4 24/2521 Nov 2025 - Revenue and profit margins declined, but cash flow and long-term outlook remain strong.RELAXO
Q2 25/2614 Nov 2025 - Q1FY26 profit and EPS rose despite lower revenue, with margin gains and strong cash flow.RELAXO
Q1 25/2631 Jul 2025